CHEK - Check-Cap Ltd.
NASDAQ
->
Healthcare
->
Diagnostics & Research
Isfiya,
Israel
Type: Equity
CHEK price evolution
CHEK
| (in millions $) | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $28.77 | $33.26 | $38.5 | $42.63 |
| Long term investments | ||||
| Property, plant & equipment | $0.26 | $0.47 | $2.81 | $2.81 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $29.03 | $33.73 | $41.31 | $45.44 |
| Current liabilities | ||||
| Accounts payable | $0.11 | $0.78 | $1.18 | $0.95 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1.64 | $3.54 | $3.56 | $3.41 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1.64 | $3.54 | $4.29 | $4.13 |
| Shareholders' equity | ||||
| Retained earnings | -$141.2 | -$138.61 | -$131.74 | -$127.29 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $26.46 | $7.7 | $7.68 | |
| Short term investments | $25.12 | $10.09 | $0.01 | |
| Net receivables | $0.21 | $0.14 | $0.16 | |
| Inventory | ||||
| Total current assets | $42.63 | $52.75 | $18.42 | $8.44 |
| Long term investments | ||||
| Property, plant & equipment | $2.81 | $2.91 | $1.22 | $0.99 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.22 | $0.99 | ||
| Total investments | ||||
| Total assets | $45.44 | $55.66 | $19.64 | $9.43 |
| Current liabilities | ||||
| Accounts payable | $0.95 | $1.05 | $0.86 | $0.99 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $3.41 | $4.04 | $2.98 | $2.8 |
| Long term debt | ||||
| Total noncurrent liabilities | $0.28 | $0.39 | ||
| Total debt | ||||
| Total liabilities | $4.13 | $4.97 | $3.26 | $3.19 |
| Shareholders' equity | ||||
| Retained earnings | -$127.29 | -$108.19 | -$90.98 | -$77.14 |
| Other shareholder equity | ||||
| Total shareholder equity | $50.69 | $16.38 | $6.23 | |
| (in millions $) | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $2.86 | $6.06 | $4.85 | $4.21 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | $0.55 | $0.41 | $0.5 | |
| Net income | ||||
| Net income | -$2.59 | -$6.88 | -$4.44 | -$3.71 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2023 | 31 Jan 2022 | 30 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $10.01 | $10.47 | ||
| Selling, general & administrative | $3.92 | $3.6 | ||
| Total operating expenses | $20.03 | $13.93 | $14.07 | |
| Operating income | -$13.93 | -$14.07 | ||
| Income from continuing operations | ||||
| EBIT | -$13.93 | -$14.07 | ||
| Income tax expense | ||||
| Interest expense | $0.89 | |||
| Net income | ||||
| Net income | -$19.11 | -$13.85 | -$13.84 | |
| Income (for common shares) | -$13.85 | -$13.84 | ||
| (in millions $) | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $4.5 | $7.99 | $17 | -$12.51 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $8.85 | |||
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.91 | -$1.84 | $12.38 | -$22.37 |
| (in millions $) | 31 Jan 2023 | 30 Dec 2021 | 30 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Net income | -$17.2 | -$13.85 | -$13.84 | |
| Operating activities | ||||
| Depreciation | $0.2 | $0.15 | $0.12 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$16.26 | -$13.11 | -$12.84 | |
| Investing activities | ||||
| Capital expenditures | -$1.01 | -$0.38 | -$0.17 | |
| Investments | -$15 | -$10.07 | $5.61 | |
| Total cash flows from investing | -$12.51 | -$16.01 | -$10.45 | $5.45 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $8.85 | $51.02 | $23.58 | $6.51 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$22.37 | $18.75 | $0.02 | -$0.89 |
News
Fundamentals
| Market cap | $13.22M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 5.85M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$17.62M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -0.75 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$3.01 |
|---|---|
| ROA | -47.15% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 17.54 |
| Quick ratio | N/A |